Article Degradation of a novel magnesium alloy-based bioresorbable coronary scaffold in a swine coronary artery model

Sho Torii ; Akiko Yamamoto SAMURAI ORCID (National Institute for Materials ScienceROR) ; Ayako Yoshikawa ; Linhai Lu ; Makoto Sasaki ; Shoko Obuchi ; Akira Wada ; Hideo Tsukamoto ; Gaku Nakazawa ORCID

Collection

Citation
Sho Torii, Akiko Yamamoto, Ayako Yoshikawa, Linhai Lu, Makoto Sasaki, Shoko Obuchi, Akira Wada, Hideo Tsukamoto, Gaku Nakazawa. Degradation of a novel magnesium alloy-based bioresorbable coronary scaffold in a swine coronary artery model. Cardiovascular Intervention and Therapeutics. 2024, 39 (4), 428-437. https://doi.org/10.1007/s12928-024-01023-3
SAMURAI

Description:

(abstract)

The objective of the study is to investigate the safety, feasibility, and degradation profile of a novel Mg alloy-based bioresorbable coronary scaffold (JFK-PRODUCT BRS) with thin struts (110 μm). Fourteen healthy pigs received 17 JFK-PRODUCT BRSs in the coronary arteries and were sacrificed at 1, 6, 12, 18, and 26 months after implantation. Angiography, optical coherence tomography, microfocus X-ray computed tomography (μCT), scanning electron microscopy with energy-dispersive X-ray spectrometry (SEM–EDX), and histopathological evaluation were performed. The JFK-PRODUCT had a median percent late recoil of 11.28% at 1 month. The μCT observation confirmed that scaffold discontinuity reached 64.8% at 12 months with increased scaffold inner area thereafter, suggesting artery positive remodeling. The inflammation was mild, peaked at 18 months, and decreased thereafter. The SEM–EDX analysis demonstrated gradual degradation of the scaffold with formation of inorganic deposits, presumed to be calcium phosphates. It also revealed the disappearance of calcium phosphates at 26 months, achieving almost complete replacement of the scaffold by biocomponents.

Rights:

  • Creative Commons BY Attribution 4.0 International Creative Commons BY Attribution 4.0 International

    This article is licensed under a Creative Commons Attribution
    4.0 International License, which permits use, sharing, adaptation,
    distribution and reproduction in any medium or format, as long
    as you give appropriate credit to the original author(s) and the source,
    provide a link to the Creative Commons licence, and indicate if changes
    were made. The images or other third party material in this article are
    included in the article’s Creative Commons licence, unless indicated
    otherwise in a credit line to the material. If material is not included in
    the article’s Creative Commons licence and your intended use is not
    permitted by statutory regulation or exceeds the permitted use, you will
    need to obtain permission directly from the copyright holder. To view a
    copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Keyword: Percutaneous coronary intervention, Bioabsorbable magnesium scaffolds, Preclinical study, Elemental mapping, Controlled degradation profile

Date published: 2024-07-22

Publisher: Springer Science and Business Media LLC

Journal:

  • Cardiovascular Intervention and Therapeutics (ISSN: 18684300) vol. 39 issue. 4 p. 428-437

Funding:

  • AMED 18pc0101027h0001 (CiCLE)

Manuscript type: Publisher's version (Version of record)

MDR DOI:

First published URL: https://doi.org/10.1007/s12928-024-01023-3

Related item:

Other identifier(s):

Contact agent:

Updated at: 2024-10-18 16:30:14 +0900

Published on MDR: 2024-10-18 16:30:15 +0900

Filename Size
Filename CardiovascIntervTherapeutics39(2024)428-437.pdf (Thumbnail)
application/pdf
Size 3.08 MB Detail
Filename CVIT2024_supplementary.docx
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Size 6.93 MB Detail